Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Maintains a 'Buy' on Nalco Holding (NLC); Eyeing the Energy Sweetspot
-
Canaccord Genuity Reiterates a 'Buy' on Horsehead Holding (ZINC); Mind The Gap; Buy ZINC
-
Canaccord Genuity Reiterates a 'Buy' on Riverbed Technology (RVBD); Meeting Takeaways
-
Canaccord Genuity Maintains a 'Hold' on IAC/InterActiveCorp (IACI); Makes Offer for Meetic
-
UPDATE - Canaccord Genuity Downgraded Nokia (NOK) to Hold; Device Sales Likely Remain Weak During Transition Period
-
Canaccord Genuity Downgrades Nokia (NOK) to Hold
-
Canaccord Genuity: Global Steelmakers Capacity Additions Positive For Industry Supply Chain - Reiterates 'Buy' on SCHN, SMS, MEA, GTI & HSC
-
Canaccord Genuity reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); High Chance of DR Cysteamine Cystinosis Phase 3 Success, FDA Approval
-
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Eyes on Launch Following DIFICID Approval
-
Canaccord Genuity Maintains a 'Hold' on Echelon (ELON); Meeting with Management
-
Canaccord Genuity Reiterates a 'Buy' on Mentor Graphics (MENT); Tops Estimates, Sees Strong H2 Although July View Soft
-
Canaccord Genuity Maintains a 'Hold' on Volcano Corp. (VOLC); No Change To Thesis on New STJ Lawsuit
-
Canaccord Genuity Reiterates a 'Buy' on Itron (ITRI); 2015 Comes Into Focus
-
Canaccord Genuity Reiterates a 'Buy' on 3D Systems (DDD); Impressive Analyst Day
-
Canaccord Genuity Reiterates a 'Hold' on OmniVision Technologies (OVTI); Guidance In-Line, but ASP & Production Concerns Likely to Weigh
-
Canaccord Genuity Reiterates a 'Buy' on Magma Design (LAVA); Strong FQ4 Results with F2011 Bookings Above Guidance
-
Canaccord Genuity Maintains a 'Hold' on Noble Corporation (NE); More Downtime Reduces Near-Term EPS
-
UPDATE - Canaccord Genuity Initiates Coverage on AcelRx Pharmaceuticals (ACRX) with a Buy; Next-Gen PCA with New Drug-Device Combo Therapies
-
Canaccord Genuity Reiterates a 'Buy' on Kadant (KAI); New Acquisition Offers Interesting Growth Possibilities
-
Canaccord Genuity Maintains a 'Hold' on Yahoo! (YHOO); Investor Day 2011
-
Canaccord Genuity Reiterates a 'Buy' on NetApp (NTAP); Thesis Tracking; Raising PT
-
Canaccord Genuity Starts AcelRx Pharmaceuticals (ACRX) at Buy
-
Canaccord Genuity on Energy - Oilfield Services: Notes From The Road: Permian Basin Tour
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Senate Nuedexta Price Inquiry; Don't See Real Risk
-
Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); LC Bead Exit Stymies Growth, but Still See Value
-
Canaccord Genuity Maintains a 'Buy' on Nexxus Lighting (NEXS); Great Opportunity
-
Canaccord Genuity Maintains a 'Buy' on Canadian Solar (CSIQ); Post Q1 Comments
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); Emerging Market 3G Sub Growth Positive for Long-Term Growth
-
Canaccord Genuity Reiterates a 'Buy' on Nokia (NOK); Smartphone Transition on Track, Dual-SIM Products Key for H2/11
-
Canaccord Genuity Reiterates a 'Buy' on Cogo Group (COGO); China Handset Trends Positive for COGO, Fundamentals Intact
-
UPDATE - Canaccord Genuity Upgraded Spreadtrum Communications (SPRD) to Buy; Share Gains Should Continue
-
Canaccord Genuity Upgrades Spreadtrum Communications (SPRD) to Buy
-
Canaccord Genuity Reiterates a 'Buy' on LeMaitre Vascular (LMAT); We Favor the Two Strategic Initiatives
-
Canaccord Genuity Maintains a 'Hold' on LSI Industries (LYTS); Look Into Q3
-
Canaccord Genuity Maintains a 'Buy' on Netflix (NFLX); For Tuesday: "Mad Men" Season 7
-
GE (GE) Denies Cree (CREE) 60W Bulb Contract
-
Cree (CREE) Jumps After Canaccord Genuity Says Company Finally Won GE (GE)
-
Canaccord Genuity Upgrades Bank of Nova Scotia (BNS) to Buy
-
Canaccord Genuity: Green Building Semimonthly
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Raising PT on Strong MARINE Data Detail at NLA
-
Canaccord Genuity Reiterates a 'Buy' on Herbalife (HLF); China: Yet Another Quality Daily Consumption Opportunity
-
Canaccord Genuity Maintains a 'Buy' on salesforce.com (CRM); Strong Results Highlighted by Accelerating Growth
-
Canaccord Genuity Reiterates a 'Buy' on Autodesk (ADSK); Best In Class Design Firm
-
Canaccord Genuity Downgrades Intuit (INTU) to Hold
-
Canaccord Genuity Reiterates a 'Buy' on Stryker (SYK); Analyst Day Take-Aways; Fine-Tuning Model to Reflect Historical Changes
-
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Sutent Phase III CRPC Data Portends Cabo Risks
-
Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Model Revisions Ahead of DIFICID Launch
-
Canaccord Genuity Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Further Support for Nexavar in Breast Cancer
-
Canaccord Genuity Reiterates a 'Buy' on AVEO Pharmaceuticals (AVEO); AXIS Subgroup Results Support TIVO Success
-
Canaccord Genuity Maintains a 'Buy' on Orion Energy Systems (OESX); A Bright Outlook for F2012
